Who We Are and What We do

Since its founding in 2008, Pathway Genomics has become known for its dedication to innovation – making it a leader in the commercial healthcare industry. Focusing on providing users with the most validated and personalized healthcare information delivered to any device, the company’s program with IBM Watson is the first of its kind to merge artificial intelligence and deep learning with precision medicine, applicable to both consumers and providers.

Based in San Diego, the company’s CLIA and CAP accredited clinical laboratory provides physicians and their patients in more than 40 different countries with actionable and accurate precision healthcare information to improve, or maintain, health and wellness. Pathway Genomics’ testing services cover a variety of conditions including somatic and hereditary cancer, cardiac health, carrier screening, diet and weight loss, as well as drug response for specific medications including those used in pain management and mental health.



Liquid Biopsy


Cancer Risk


Cardiac Health


Carrier Screening


Medication Response


Weight Management


Pathway Genomics Supports the Free the Data Movement

Pathway Genomics agrees with the Free the Data movement — genetic mutations should not be trade secrets. By broadening access and sharing genetic information, we can collectively harness the power of the genome to improve our understanding of disease and improve healthcare for everyone. Providing broad access to genetic testing will allow the medical community to collectively diagnose disease better, faster and cheaper — offering patients more effective healthcare and reducing costs to the healthcare system. Learn more about the movement.